| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 52, 1264-1266, Copyright © 1981 by Endocrine Society
ARTICLES |
WB Zipf, TM O'Dorisio, S Cataland and J Sotos
Serum pancreatic polypeptide (PP), gastric inhibitory polypeptide (GIP), insulin and glucose responses to meal stimulation were studied in 10 normal weight patients, 13 normal obese patients and 7 patients with Prader-Willi syndrome (PWS) associated obesity. Serum and plasma concentrations of PP, glucose, insulin and GIP were obtained at 15 min intervals from 0-180 min. after a 275 K calorie meal. Basal and peak responses of glucose, for patients with PWS were significantly lower when compared to normal or obese controls. Basal and peak insulin responses in PWS were significantly greater than those of the normal controls but still less than those of the obese controls. Basal GIP concentrations in the patients with PWS were significantly less than normals and their peak response was less than the obese control group. No significant differences in basal or peak PP responses were noted between normal and obese controls. All 7 patients with PWS had abnormal PP responses. Five failed to show significant PP release after the stimulation; one had a peak response to 130 pg/ml while the 7th patient (PB) had an exaggerated response to 2000 pg/ml. The 6 patients with low or no response had basal PP values of 62 +/- 12 pg/ml and a mean PP peak response of 78 +/- 15 pg/ml. This observation of blunted PP response in a human model of hyperphagia and obesity parallels the animal models and suggests PP may have a significant role in appetite control.
This article has been cited by other articles:
![]() |
J. J. Hwang, J. L. Chan, G. Ntali, D. Malkova, and C. S. Mantzoros Leptin Does Not Directly Regulate the Pancreatic Hormones Amylin and Pancreatic Polypeptide: Interventional studies in humans Diabetes Care, May 1, 2008; 31(5): 945 - 951. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Stanley, K. Wynne, B. McGowan, and S. Bloom Hormonal Regulation of Food Intake Physiol Rev, October 1, 2005; 85(4): 1131 - 1158. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Goldstone, M. Patterson, N. Kalingag, M. A. Ghatei, A. E. Brynes, S. R. Bloom, A. B. Grossman, and M. Korbonits Fasting and Postprandial Hyperghrelinemia in Prader-Willi Syndrome Is Partially Explained by Hypoinsulinemia, and Is Not Due to Peptide YY3-36 Deficiency or Seen in Hypothalamic Obesity Due to Craniopharyngioma J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 2681 - 2690. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Wynne, S. Stanley, B. McGowan, and S. Bloom Appetite control J. Endocrinol., February 1, 2005; 184(2): 291 - 318. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Koska, A. DelParigi, B. de Courten, C. Weyer, and P. A. Tataranni Pancreatic Polypeptide Is Involved in the Regulation of Body Weight in Pima Indian Male Subjects Diabetes, December 1, 2004; 53(12): 3091 - 3096. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Wynne, S. Stanley, and S. Bloom The Gut and Regulation of Body Weight J. Clin. Endocrinol. Metab., June 1, 2004; 89(6): 2576 - 2582. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. Salbe, M. H. Tschop, A. DelParigi, C. A. Venti, and P. A. Tataranni Negative Relationship between Fasting Plasma Ghrelin Concentrations and ad Libitum Food Intake J. Clin. Endocrinol. Metab., June 1, 2004; 89(6): 2951 - 2956. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Goldstone, E. L. Thomas, A. E. Brynes, G. Castroman, R. Edwards, M. A. Ghatei, G. Frost, A. J. Holland, A. B. Grossman, M. Korbonits, et al. Elevated Fasting Plasma Ghrelin in Prader-Willi Syndrome Adults Is Not Solely Explained by Their Reduced Visceral Adiposity and Insulin Resistance J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1718 - 1726. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. DelParigi, M. Tschop, M. L. Heiman, A. D. Salbe, B. Vozarova, S. M. Sell, J. C. Bunt, and P. A. Tataranni High Circulating Ghrelin: A Potential Cause for Hyperphagia and Obesity in Prader-Willi Syndrome J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5461 - 5464. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |